TMUB1

gene
On this page

Also known as SB144HOPS

Summary

TMUB1 (transmembrane and ubiquitin like domain containing 1, HGNC:21709) is a protein-coding gene on chromosome 7q36.1, encoding Transmembrane and ubiquitin-like domain-containing protein 1 (Q9BVT8). Involved in sterol-regulated ubiquitination and degradation of HMG-CoA reductase HMGCR.

Involved in ERAD pathway. Predicted to be located in several cellular components, including centrosome; postsynaptic membrane; and recycling endosome. Predicted to be active in postsynaptic recycling endosome membrane.

Source: NCBI Gene 83590 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 37 total
  • MANE Select transcript: NM_001136044

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21709
Approved symbolTMUB1
Nametransmembrane and ubiquitin like domain containing 1
Location7q36.1
Locus typegene with protein product
StatusApproved
AliasesSB144, HOPS
Ensembl geneENSG00000164897
Ensembl biotypeprotein_coding
OMIM614792
Entrez83590

Gene structure

Transcript identifiers

Ensembl transcripts: 15 — 15 protein_coding

ENST00000297533, ENST00000392818, ENST00000462940, ENST00000476627, ENST00000482202, ENST00000488752, ENST00000492838, ENST00000653405, ENST00000873650, ENST00000873651, ENST00000873652, ENST00000873653, ENST00000873654, ENST00000924882, ENST00000924883

RefSeq mRNA: 2 — MANE Select: NM_001136044 NM_001136044, NM_031434

CCDS: CCDS5920

Canonical transcript exons

ENST00000297533 — 3 exons

ExonStartEnd
ENSE00001088367151082175151082593
ENSE00001088369151083434151083493
ENSE00001825881151081085151081900

Expression profiles

Bgee: expression breadth ubiquitous, 139 present calls, max score 96.33.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.2561 / max 226.8990, expressed in 1809 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
8686420.25721804
868631.4343367
868650.5647320

Top tissues by expression

141 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mucosa of transverse colonUBERON:000499196.33gold quality
right lobe of liverUBERON:000111495.87gold quality
lower esophagus mucosaUBERON:003583495.79gold quality
body of pancreasUBERON:000115095.66gold quality
thymusUBERON:000237095.27silver quality
body of stomachUBERON:000116195.04gold quality
hindlimb stylopod muscleUBERON:000425294.65gold quality
gastrocnemiusUBERON:000138894.57gold quality
adenohypophysisUBERON:000219694.48gold quality
fundus of stomachUBERON:000116094.44gold quality
pituitary glandUBERON:000000794.29gold quality
apex of heartUBERON:000209894.28gold quality
granulocyteCL:000009493.81gold quality
small intestine Peyer’s patchUBERON:000345493.50gold quality
duodenumUBERON:000211493.44gold quality
muscle of legUBERON:000138393.34gold quality
transverse colonUBERON:000115793.30gold quality
metanephros cortexUBERON:001053393.28gold quality
small intestineUBERON:000210893.13gold quality
liverUBERON:000210793.09gold quality
right lobe of thyroid glandUBERON:000111993.01gold quality
left lobe of thyroid glandUBERON:000112092.82gold quality
lower esophagusUBERON:001347392.80gold quality
lower esophagus muscularis layerUBERON:003583392.80gold quality
adult mammalian kidneyUBERON:000008292.60gold quality
muscle layer of sigmoid colonUBERON:003580592.58gold quality
mucosa of stomachUBERON:000119992.56gold quality
esophagogastric junction muscularis propriaUBERON:003584192.48gold quality
bloodUBERON:000017892.46gold quality
popliteal arteryUBERON:000225092.41gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes7.24
E-MTAB-6379no52.29

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

11 targeting TMUB1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-128-3P99.9571.172484
HSA-MIR-216A-3P99.9571.192505
HSA-MIR-3681-3P99.8870.462254
HSA-MIR-450599.2767.812678
HSA-MIR-578799.2267.862628
HSA-MIR-6793-3P97.6665.781084
HSA-MIR-191397.0766.201417
HSA-MIR-5587-3P82.9060.79138

Literature-anchored findings (GeneRIF, showing 7)

  • a novel ubiquitin-like molecule DULP from human dendritic cells was identified. (PMID:19254477)
  • TMUB1 promoted the expression of STAT1, and suppressed the expression of CCND1 in HCC cells. TMUB1 negatively regulates hepatocellular carcinoma proliferation via regulating STAT1. (PMID:31827061)
  • The Ins and Outs of HOPS/TMUB1 in biology and pathology. (PMID:32860479)
  • TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for Colorectal Cancer. (PMID:35928927)
  • Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation. (PMID:36376293)
  • Inhibition of TMUB1 blocks apoptosis and NF-kappaB pathway-mediated inflammation in recurrent spontaneous abortion. (PMID:37249279)
  • TMUB1 expression is associated with the prognosis of colon cancer and immune cell infiltration. (PMID:38025742)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriotmub1ENSDARG00000038787
mus_musculusTmub1ENSMUSG00000028958
rattus_norvegicusTmub1ENSRNOG00000013383
caenorhabditis_elegansWBGENE00015126

Paralogs (1): TMUB2 (ENSG00000168591)

Protein

Protein identifiers

Transmembrane and ubiquitin-like domain-containing protein 1Q9BVT8 (reviewed: Q9BVT8)

Alternative names: Dendritic cell-derived ubiquitin-like protein, Hepatocyte odd protein shuttling protein, Ubiquitin-like protein SB144

All UniProt accessions (5): A0A090N8Q3, A0A590UJA9, C9JCW7, C9JE12, Q9BVT8

UniProt curated annotations — full annotation on UniProt →

Function. Involved in sterol-regulated ubiquitination and degradation of HMG-CoA reductase HMGCR. Involved in positive regulation of AMPA-selective glutamate receptor GRIA2 recycling to the cell surface. Acts as a negative regulator of hepatocyte growth during regeneration. May contribute to the regulation of translation during cell-cycle progression. May contribute to the regulation of cell proliferation. May be involved in centrosome assembly. Modulates stabilization and nucleolar localization of tumor suppressor CDKN2A and enhances association between CDKN2A and NPM1.

Subunit / interactions. Interacts with EEF1A1, GRIA2, GRIP1, CAMLG, TUBG1. Interacts with NPM1 and CDKN2A; TMUB1 can enhance interaction between NPM1 and CDKN2A and is proposed to bridge the proteins; proposed to be mediated by iHOPS. Interacts with ERLIN2 and AMFR; TMUB1 promotes the interaction of ERLIN2 with AMFR.

Subcellular location. Membrane. Postsynaptic cell membrane. Recycling endosome. Cytoplasm. Nucleus. Nucleolus Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Nucleolus.

Tissue specificity. Ubiquitously expressed with highest levels in mammary and thyroid glands, bone marrow and spleen; limited expression in cardiac, pancreatic and ovarian tissues.

Post-translational modifications. Processed by regulated intramembrane proteolysis (RIP)in the N-terminus to release iHOPS from membranes.

RefSeq proteins (2): NP_001129516, NP_113622 (=MANE)

Domains & families (InterPro)

IDNameType
IPR000626Ubiquitin-like_domDomain
IPR029071Ubiquitin-like_domsfHomologous_superfamily
IPR040352TMUB1/2Family

Pfam: PF00240

UniProt features (14 total): modified residue 5, transmembrane region 3, chain 2, region of interest 2, domain 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BVT8-F167.200.04

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (5): 73, 92, 98, 127, 71

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 78 (showing top): GOBP_RESPONSE_TO_NITROGEN_COMPOUND, GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOCC_CENTROSOME, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, GOBP_ERAD_PATHWAY, GOBP_PROTEIN_CATABOLIC_PROCESS, GOCC_POSTSYNAPSE, GOCC_SYNAPSE, GOCC_POSTSYNAPTIC_MEMBRANE, GOBP_PROTEOLYSIS, GOCC_PLASMA_MEMBRANE_REGION, GOCC_NUCLEOLUS, GOCC_RECYCLING_ENDOSOME

GO Biological Process (1): ERAD pathway (GO:0036503)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (11): nucleolus (GO:0005730), centrosome (GO:0005813), postsynaptic membrane (GO:0045211), recycling endosome (GO:0055037), nucleus (GO:0005634), cytoplasm (GO:0005737), endosome (GO:0005768), cytoskeleton (GO:0005856), plasma membrane (GO:0005886), membrane (GO:0016020), synapse (GO:0045202)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intracellular membraneless organelle2
cellular anatomical structure2
proteasomal protein catabolic process1
response to endoplasmic reticulum stress1
response to chemical1
binding1
nuclear lumen1
centriole1
microtubule organizing center1
synaptic membrane1
postsynapse1
endosome1
intracellular membrane-bounded organelle1
intracellular anatomical structure1
endomembrane system1
cytoplasmic vesicle1
membrane1
cell periphery1
cell junction1

Protein interactions and networks

STRING

814 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TMUB1TMEM259Q4ZIN3851
TMUB1ERLIN2O94905747
TMUB1RNF185Q96GF1701
TMUB1AMFRP26442660
TMUB1ERLIN1O75477625
TMUB1A0A2R8Y422A0A2R8Y422576
TMUB1FAM8A1Q9UBU6574
TMUB1RNF170Q96K19557
TMUB1TMEM126AQ9H061546
TMUB1C6orf120Q7Z4R8495
TMUB1UBE2G2P56554461
TMUB1TMEM53Q6P2H8461
TMUB1TMUB2Q71RG4456
TMUB1UBE2J1Q9Y385456
TMUB1PLEKHM1Q9Y4G2446

IntAct

74 interactions, top by confidence:

ABTypeScore
ERLIN1ERLIN2psi-mi:“MI:0914”(association)0.740
ERLIN2TMUB1psi-mi:“MI:0915”(physical association)0.660
ERLIN2TMUB1psi-mi:“MI:0914”(association)0.660
TMUB1ERLIN2psi-mi:“MI:0915”(physical association)0.660
TMUB1ERLIN2psi-mi:“MI:0914”(association)0.660
TMUB1AMFRpsi-mi:“MI:0915”(physical association)0.560
SGTBTMUB1psi-mi:“MI:0915”(physical association)0.560
GOLM1TMUB1psi-mi:“MI:0915”(physical association)0.560
TMBIM6TMUB1psi-mi:“MI:0915”(physical association)0.560
TMUB1TMEM14Bpsi-mi:“MI:0915”(physical association)0.560
TMUB1JPH3psi-mi:“MI:0915”(physical association)0.560
ADGRG5KLRG2psi-mi:“MI:0914”(association)0.530
RIC3ATP9Apsi-mi:“MI:0914”(association)0.530
DUSP3ERLIN1psi-mi:“MI:0914”(association)0.530
ANKHFAM234Bpsi-mi:“MI:0914”(association)0.530
TMUB1SYVN1psi-mi:“MI:0915”(physical association)0.400
RNF139TMUB1psi-mi:“MI:0915”(physical association)0.400
KISS1RERLIN1psi-mi:“MI:0915”(physical association)0.400
ERLIN2psi-mi:“MI:0914”(association)0.350
CHRNA9TMEM120Bpsi-mi:“MI:0914”(association)0.350
KCNK16EMC8psi-mi:“MI:0914”(association)0.350
RIC3ATP9Apsi-mi:“MI:0914”(association)0.350
TMUB2ERLIN1psi-mi:“MI:0914”(association)0.350
NBASpsi-mi:“MI:0914”(association)0.350

BioGRID (152): TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS), TMUB1 (Affinity Capture-MS)

ESM2 similar proteins: A7E3N7, B1AVH7, B5DFA1, D2H0G5, D3ZZN9, E9PY61, E9Q6X9, O75425, O95382, Q0QWG9, Q24JP5, Q3T033, Q3ZBI9, Q53AQ4, Q5TG30, Q60806, Q6F5E8, Q6PGG2, Q6V7V2, Q6ZW31, Q76MJ5, Q7Z465, Q80WF4, Q8BGG6, Q8C0R7, Q8C6B2, Q8CJ00, Q8R2K4, Q8WVB6, Q91WA6, Q922P8, Q924T7, Q969H4, Q96EP0, Q96F46, Q99JU7, Q9BST9, Q9BVT8, Q9BXM7, Q9DBZ9

Diamond homologs: P34256, Q2HJA8, Q3KPV4, Q3V209, Q3ZBI9, Q4FZV7, Q4V9Y1, Q53AQ4, Q6P135, Q71RG4, Q9BVT8, Q9JMG3

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 75 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Calnexin/calreticulin cycle570.0×2e-06
N-glycan trimming in the ER and Calnexin/Calreticulin cycle541.5×1e-05
Defective CFTR causes cystic fibrosis521.5×2e-04
AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274)519.0×2e-04
ABC-family protein mediated transport511.9×2e-03
SLC-mediated transmembrane transport89.3×1e-04
Transport of small molecules115.4×2e-04

GO biological processes:

GO termPartnersFoldFDR
ERAD pathway924.7×4e-08
transmembrane transport615.3×4e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

37 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance35
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

681 predictions. Top by Δscore:

VariantEffectΔscore
7:151081901:C:CCacceptor_gain1.0000
7:151081902:T:Cacceptor_loss1.0000
7:151082171:TTA:Tdonor_loss1.0000
7:151082173:A:ACdonor_gain1.0000
7:151082174:C:CCdonor_gain1.0000
7:151083432:ACCGC:Adonor_gain1.0000
7:151083433:CCGCC:Cdonor_gain1.0000
7:151081896:GGGTC:Gacceptor_gain0.9900
7:151081898:GTC:Gacceptor_gain0.9900
7:151081899:TC:Tacceptor_gain0.9900
7:151081900:CC:Cacceptor_gain0.9900
7:151082170:CTTA:Cdonor_gain0.9900
7:151082173:AC:Adonor_gain0.9900
7:151082174:CC:Cdonor_gain0.9900
7:151082174:CCT:Cdonor_gain0.9900
7:151082174:CCTT:Cdonor_gain0.9900
7:151082174:CCTTT:Cdonor_gain0.9900
7:151082498:C:CTacceptor_gain0.9900
7:151082589:CCGAG:Cacceptor_gain0.9900
7:151082590:CGAG:Cacceptor_gain0.9900
7:151082590:CGAGC:Cacceptor_gain0.9900
7:151082594:C:CCacceptor_gain0.9900
7:151083426:GGACT:Gdonor_loss0.9900
7:151083427:GACT:Gdonor_loss0.9900
7:151083428:ACTC:Adonor_loss0.9900
7:151083429:CTC:Cdonor_loss0.9900
7:151083430:TCA:Tdonor_loss0.9900
7:151083431:CA:Cdonor_loss0.9900
7:151083432:A:ACdonor_gain0.9900
7:151083432:A:Tdonor_loss0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000693573 (7:151080811 G>A), RS1001512726 (7:151080781 G>A,C), RS1002326513 (7:151084183 A>T), RS1002778273 (7:151083886 C>A,T), RS1003410218 (7:151082946 T>G), RS1003777174 (7:151082696 C>T), RS1004651210 (7:151084221 C>T), RS1004810846 (7:151081378 A>G,T), RS1005918073 (7:151084827 C>A,T), RS1006494715 (7:151085034 C>A), RS1006714174 (7:151081140 T>C), RS1007097750 (7:151081454 C>T), RS1008503443 (7:151082238 A>G,T), RS1009507801 (7:151080891 C>G,T), RS1009944318 (7:151085453 G>A,C)

Disease associations

OMIM: gene MIM:614792 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST003476_9Eyebrow thickness7.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

16 total (human), top 16 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases expression3
aristolochic acid Iincreases expression1
beta-lapachonedecreases expression1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic acidincreases expression1
abrinedecreases expression1
(+)-JQ1 compounddecreases expression1
MT19c compounddecreases expression1
Acetaminophendecreases expression1
Air Pollutantsincreases abundance, increases expression1
Arsenicaffects methylation1
Caffeineaffects phosphorylation1
Gallic Acidincreases expression1
Tobacco Smoke Pollutionincreases expression1
Copper Sulfatedecreases expression1
Particulate Matterincreases abundance, increases expression1

Cellosaurus cell lines

2 cell lines: 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B2IXAbcam HeLa TMUB1 KOCancer cell lineFemale
CVCL_B2IYAbcam HeLa TMUB1 partial KOCancer cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.